CHRISTOPHER BATISTA: Open Payments
NPI 1245566108 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,897 in 203 payments from 21 companies in 2025. Trend: 2023 $3,128 · 2024 $2,898 · 2025 $3,897
Food & beverage: $3,897
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 78 | $1,419 |
| Amgen Inc. | 22 | $375 |
| Madrigal Pharmaceuticals | 11 | $305 |
| UCB, Inc. | 14 | $304 |
| Novartis Pharmaceuticals Corporation | 19 | $281 |
| AstraZeneca Pharmaceuticals LP | 9 | $279 |
| Janssen Biotech, Inc. | 13 | $268 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $180 |
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| GlaxoSmithKline, LLC. | 5 | $84 |
Products named: RINVOQ, SKYRIZI, REZDIFFRA, Bimzelx, COSENTYX, SAPHNELO, TREMFYA, XIFAXAN.
Industry payments across TX — which companies pay providers there.
